Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 29, 2015, to consider and approve the Audited Financial Results for the Financial Year 2014-2015, Financial Statement of the Company for the Financial Year 2014-15 matters related thereto and Recommendation of final dividend to the Members of the Company for the Financial Year 2014-15.
The above information is a part of company’s filings submitted to BSE.